BIOARRAY Genetics

BIOARRAY Genetics

BIOARRAY Genetics

Revolutionizing cancer treatment decisions with patient-specific precision tests
Type
B2b
Raised
$4M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$4,000,000
Venture capital (Series B) - 2017
Connecticut Innovations Quark Venture GF Securities
Team Size
1–10
Employees
$4,000,000 Venture capital (Series B)
PE HUB

Personalized medicine startup Bioarray Genetics fetches $4 mln Series B